These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1484969)

  • 1. Flow cytometric steroid receptor analysis.
    Schutte B; Scheres HM; De Goeij AF; Rousch MJ; Blijham GH; Bosman FT; Ramaekers FC
    Prog Histochem Cytochem; 1992; 26(1-4):68-76. PubMed ID: 1484969
    [No Abstract]   [Full Text] [Related]  

  • 2. [Expression of estrogen receptors in breast cancer detected by various methods: lack of correlation].
    Barbareschi M; Losi L; Capitanio G; Dittadi R; Gion M; Ludvìkovà M; Fina P; Dalla Palma P; Eusebi V
    Pathologica; 1997 Aug; 89(4):397-404. PubMed ID: 9471608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study.
    Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S
    Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibodies in the immunohistochemical detection of estrogen and progesterone receptor status in breast carcinoma].
    Shui R; Yang W
    Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):229-31. PubMed ID: 25975902
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical-biological characteristics of infiltrating ductal carcinomas of the breast with estrogen receptor concentrations >300 fmol/mg protein].
    Resino C; Arias JI; Del Río MC; Sánchez Hermosa C; Ruibal A
    Rev Esp Med Nucl; 2001 Oct; 20(6):503-5. PubMed ID: 11578586
    [No Abstract]   [Full Text] [Related]  

  • 6. Demonstration of oestrogen receptor in symptomatic breast carcinoma, using fine needle aspiration cytology.
    Cuthbert A; Herbert A; Coddington R; Theaker J; Taylor I; Royle GT
    Cytopathology; 1990; 1(6):339-47. PubMed ID: 2101680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine-needle aspiration technique for the concurrent immunocytochemical evaluation of multiple biologic parameters in primary breast carcinoma.
    Bozzetti C; Nizzoli R; Naldi N; Manotti L; Savoldi L; Camisa R; Guazzi A; Cocconi G
    Breast Cancer Res Treat; 1994; 32(2):221-8. PubMed ID: 7865851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of estrogen and progesterone receptors in human breast cancer cytosols: a comparison between radioligand binding assay (DCC) and enzyme immunoassay (EIA).
    Cerra M; Cecco L; Montella M; Celentano E; Bonelli P; Tuccillo F
    Int J Biol Markers; 1996; 11(1):50-2. PubMed ID: 8740643
    [No Abstract]   [Full Text] [Related]  

  • 9. [Receptor status (ER and PgR) determined with histochemical and biochemical methods in breast carcinoma].
    Simone G; Paradiso A; Cirillo R; Mangia A; Rella G; Wiesel S; Petroni S; De Benedictis G; De Lena M
    Pathologica; 1991; 83(1086):449-59. PubMed ID: 1724316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
    Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
    Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.
    Brown DL; Cole BF; Arrick BA
    J Natl Cancer Inst; 1999 Jan; 91(1):90-1. PubMed ID: 9890178
    [No Abstract]   [Full Text] [Related]  

  • 12. Steroid receptor assays: an Italian quality assessment program.
    Piffanelli A; Giovannini G; Pelizzola D; De Bortoli M; Catozzi L; Giganti M
    Ann Ist Super Sanita; 1991; 27(3):523-9. PubMed ID: 1809075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging features of invasive breast cancer correlated with hormonal receptors: does progesterone receptor matter?
    Chen JH; Nalcioglu O; Su MY
    Ann Oncol; 2008 May; 19(5):1024-6. PubMed ID: 18375524
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunohistochemical hormonal mismatch and human epidermal growth factor type 2 [HER2] phenotype of brain metastases in breast cancer carcinoma compared to primary tumors].
    Joubert C; Boissonneau S; Fina F; Figarella-Branger D; Ouafik L; Fuentes S; Dufour H; Gonçalves A; Charaffe-Jauffret E; Metellus P
    Neurochirurgie; 2016 Jun; 62(3):151-6. PubMed ID: 27236733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical quantification of steroid receptors and other prognosis factors in human breast cancer patients.
    Fritz P; Tuczek HV; Offinger B; Schwarzmann P; Schieszl S; Wu X; Kleine B; Blödorn J; Multhaupt H
    Prog Histochem Cytochem; 1992; 26(1-4):146-58. PubMed ID: 1283015
    [No Abstract]   [Full Text] [Related]  

  • 16. Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry.
    Stål O; Sullivan S; Sun XF; Wingren S; Nordenskjöld B
    Cytometry; 1994 Jun; 16(2):160-8. PubMed ID: 7924685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and progesterone receptor expression and proliferation in breast cancer cells, studied with flow cytometry.
    Scheres HM; Schutte B; De Goij AF; Bosman FT
    Acta Histochem Suppl; 1990; 40():71-6. PubMed ID: 2091049
    [No Abstract]   [Full Text] [Related]  

  • 18. Déjà vu for breast cancer two?
    Stearns V; Davidson NE
    J Natl Cancer Inst; 2004 Apr; 96(7):497-9. PubMed ID: 15069104
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic targeting in breast cancer].
    Penault-Llorca F
    Ann Pathol; 2009 Nov; 29 Spec No 1():S71-3. PubMed ID: 19887259
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hormone-dependent, diploid, infiltrating ductal breast carcinomas less than 2 cm in size: influence of an exclusive and moderate cellular proliferation on the clinicobiological features and recurrences of these malignant tumors].
    Ruibal A; Arias JI
    Rev Esp Med Nucl; 2002; 21(6):437-8. PubMed ID: 12425893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.